Patient info Open main menu

Clobavate 0.05%w/w ointment – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

Medicine strength:
0.05%w/w (500 microgram/gram)
Contains active substance:

Patient leaflet - Clobavate 0.05%w/w ointment

1. What is Clobetasone Butyrate Ointment and what is it used for

Clobetasone Butyrate Ointment contains the active ingredient clobetasone butyrate. This belongs to a group of medicines called steroids. It helps to reduce swelling and irritation.

Clobetasone Butyrate Ointment is used to help reduce the redness and itchiness of certain skin problems. It is used for mild skin problems or to keep your skin problems under control. These skin problems include eczema, dermatitis, nappy rash or insect bites. It is also used to help reduce inflammation of the outer ear.

2. What you need to know before you use Clobetasone Butyrate Ointment

Do not use Clobetasone Butyrate Ointment:

  • if you are allergic to clobetasone butyrate or any of the other ingredients of this medicine (listed in Section 6)
  • to treat any of the following skin problems, it could make them worse:

    • infected skin (unless the infection is being treated with an anti-infective medicine at the same time)
    • acne
    • severe flushing of skin on and around your nose (rosacea)
    • itchy skin which is not inflamed

Do not use this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before using Clobetasone Butyrate.

Warnings and precautions

Talk to your doctor or pharmacist before using Clobetasone Butyrate if:

  • you have previously had an allergic reaction with another steroid
  • using for a chronic leg ulcer as you may be at increased risk of local allergic reaction or infection
  • you have been advised by your doctor to use this medicine under an occlusive dressing (including a child’s nappy). Make sure that the skin is cleansed before a fresh dressing is applied to prevent infections. Occlusive dressings (including a child’s nappy) make it easier for the active ingredient to pass through the skin, making is possible to accidentally use too much.
  • you are applying to thin skin such as the face, as skin is thinner and may absorb larger amounts. Dressings or bandages should not be used on the face where the ointment is applied.
  • you are applying to the face over a long period of time as it may cause skin thinning
  • you are applying the cream on broken skin or within the skin folds
  • you are applying near eyes or on eyelids, as cataracts or glaucoma may result if the cream repeatedly enters the eye
  • you experience blurred vision or other visual disturbances
  • you accidently swallow a large amount of Clobetasone Butyrate, rinse the mouth out with plenty of water and contact a doctor or pharmacist for advice immediately
  • an infection develops (see section 4, Possible side effects).

Teva UK Limited,

Ridings Point,

Whistler Drive,

Castleford,

WF10 5HX,

United Kingdom

This leaflet was last revised in January 2026.

Tiofarma B.V.,

Hermanus Boerhaavestraat 1, 3261 ME Oud-Beijerland, The Netherlands

If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking this medicine.

Do not smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.

If there is a worsening of your condition during use consult your prescriber – you may be experiencing an

allergic reaction, have an infection or your condition requires a different treatment. If you experience a recurrence of your condition shortly after stopping treatment, within 2 weeks, do not restart using the ointment without consulting your prescriber unless your prescriber has previously advised you to so. If your condition has resolved and on recurrence the redness extends beyond the initial treatment area and you experience a burning sensation, please seek medical advice before restarting treatment.

Corticosteroid creams, ointments and other topical preparations come in four different potencies or strengths. These are known as mild, moderately potent, potent or very potent. Healthcare professionals will usually refer to topical corticosteroid potency rather than strength. A potent or strong corticosteroid has a much stronger effect

than a mild corticosteroid when using the same amount. The percentage of active ingredient that is sometimes included on product packaging does not indicate potency. Clobetasone Butyrate is classed as a moderately potent corticosteroid. Your healthcare professional will prescribe or advise a steroid of the appropriate potency for your condition.

Other medicines and Clobetasone Butyrate Ointment

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Taking some medicines together can be harmful.

In particular, tell your doctor or pharmacist if you are taking or have recently taken any of the following medicines:

  • Antivirals such as ritonavir which can be used to treat HIV infection
  • Antifungals such as itraconazole which can be used to treat fungal infections

If you are unsure of the types of medicines you are taking, ask your doctor or pharmacist.

Pregnancy, breast feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

This medicine will not affect your ability to drive or use heavy machinery.

3. How to use Clobetasone Butyrate Ointment

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Using this medicine

  • You usually apply Clobetasone Butyrate up to 2 times a day. This may be reduced as your skin begins to get better.
  • This ointment is for use on your skin only.
  • Do not use on large areas of the body for a long time (such as every day for many weeks or months) – unless your doctor tells you to.
  • If you are using an emollient (moisturising) preparation allow time for Clobetasone Butyrate to be absorbed after each application before applying the emollient.
  • If you are applying the ointment on someone else make sure you wash your hands after use or wear disposable plastic gloves.
  • If your skin problem does not improve after 4 weeks, talk to your doctor.

Guidance on how to apply the ointment

  1. 1. Wash your hands.
  2. 2. Apply a thin layer to the affected area(s) and gently rub into the skin until it has all disappeared. You can measure how much Clobetasone Butyrate to use with your fingertip. For children you will need to use less ointment but still use an adult finger to measure out the fingertip unit. This picture shows one fingertip unit.
  3. 3. Unless you are meant to apply the ointment to your hands as a part of the treatment, wash them again after using the ointment.

For an adult:

You should find that:

  • two and a half fingertips of ointment will cover face and neck

    2 UNITS 3 UNITS 6 UNITS 14 UNITS

    1 ½

    2

    2

    2 ½

    3

    4 ½

    3

    3 ½

    3 ½

    5

    If you apply Clobetasone Butyrate Ointment to your face

    You should only apply the ointment to your face if your doctor tells you to. The ointment should not be used for too long as the skin on your face thins easily. Do not let the ointment get into your eyes. If it does, wash it out with plenty of water.

    If you use more Clobetasone Butyrate Ointment than you should

    If you apply a lot or if a lot is accidentally swallowed, it could make you ill. Talk to your doctor or go to hospital as soon as possible.

    If you forget to use Clobetasone Butyrate Ointment

    If you forget to apply your ointment, apply it as soon as you remember. If it is close to the time you are next meant to apply it, wait until this time.

    If you stop using Clobetasone Butyrate Ointment

    If you use Clobetasone Butyrate regularly make sure you talk to your doctor before you stop using it as your condition may get worse if stopped suddenly.

    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop using Clobetasone Butyrate Ointment and tell your doctor as soon as possible if

  • you find that your skin condition gets worse, you develop a generalised rash or your skin becomes swollen during treatment. You may be allergic to the ointment, have an infection or need other treatment.

Other side effects you may notice when using Clobetasone Butyrate include

Very rare (may affect up to 1 in 10,000 people)

  • delayed weight gain or slowing of growth in children
  • bones can become thin, weak and break easily
  • cloudy lens in the eye (cataract) or increased pressure in eye (glaucoma)
  • increased blood sugar levels or sugar in the urine
  • high blood pressure

    Not Known (frequency cannot be estimated from the available data)

    • blurred vision

Steroid withdrawal reaction: If used over prolonged periods a withdrawal reaction, which might appear to be different from the previous condition, may occur in some patients during treatment or within days to weeks after stopping treatment, with some or all of the following features: redness of the skin

which can extend beyond the initial area treated, a burning or

stinging sensation, intense itching, peeling of the skin, oozing

open sores.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Clobetasone Butyrate Ointment

Keep this medicine out of the sight and reach of children.

Store in the original package in order to protect from light.

Do not use this medicine after the expiry date which is stated on the tube or carton after EXP. The expiry date refers to the last day of that month.

This medicine should be disposed of 3 months after first opening.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other Information

What Clobetasone Butyrate Ointment contains

  • The active substance is clobetasone butyrate.

    Each 1 g contains 0.5 mg of Clobetasone butyrate (0.05% w/w).

  • The other ingredients are liquid paraffin and white soft paraffin.

What Clobetasone Butyrate Ointment looks like and contents of the pack

Clobetasone Butyrate is an opaque ointment.

Within each carton is a tube with a plastic screw cap, which contains either 30 or 100 g of ointment.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder Manufacturer

IMPORTANT: Artwork, text and content must not be reset, remade, amended or altered. The only exceptions to this are: bleeds, chokes, spreads or other print related adjustments required for reproduction by the supplier. We must receive a copy of any 3rd Party Supplier’s Proof before approval to print will be granted.

SKU (s): 32130418

32129537

(excluding codes) Perforated: Arial,

Gill Sans.

8 pt TevaArt Ref: PID: 253491_s1 P: Clobetasone Butyrate UK Ointment 0.05% w/w 30g 100g 1 TIO 06 January 2026

Version: 5

Length: Width: Depth:

297 mm

218 mm

ACHTERKANT

VOORKANT

continued overleaf

  • an increased risk of skin infection
  • an allergic skin reaction where the ointment is applied
  • a feeling of burning, irritation or itching where the ointment is applied
  • rash, itchy bumpy skin or redness of the skin
  • increased hair growth and changes in skin colour
  • thinning of your skin and it may also damage more easily
  • weight gain, rounding of the face
  • two fingertips of ointment will cover both hands or one foot
  • three fingertips of ointment will cover one arm (not including the hand)
  • one fingertip for both sides of the hand
  • six fingertips of ointment will cover one leg (not including the foot)
  • fourteen fingertips of ointment will cover the front and back of the body

Do not worry if you find you need a little more or a little less than this. It is only a rough guide.

For a child:

Number of fingertip units needed

Child’s age

3-6 months

1-2 years

1

1 ½

1

1 ½

1 ½

2

1

2

1 ½

3

Face and neck Arm and hand Leg and foot Front Back including buttocks

  • Do not use on children younger than 12 years unless advised by a doctor.
  • If the condition worsens or does not improve within 7 days, consult a doctor.
  • Once the condition improves, reduce both the amount applied and the frequency of application to the minimum necessary to relieve symptoms.
  • Do not use every day for mote than 4 weeks at a time.

    3-5 years

    6-10 years

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00289/2324

Last revision stated in the text: January 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Clobavate 0.05%w/w ointment

Active substance Clobetasone
Strength 0.05%w/w (500 microgram/gram)
Pharmaceutical form Cutaneous ointment
Opaque ointment.
How is it taken Cutaneous
Excipients Liquid paraffin, White soft paraffin
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months
In-use shelf life: 3 months.
Storage Store in the original package in order to protect from light.
Drug group (ATC) Corticosteroid, moderately potent (group II)
  1. D Dermatologicals
    1. D07 Corticosteroids, dermatological preparations
      1. D07A Corticosteroid dermatological preparations, plain
        1. D07AB Corticosteroids, moderately potent (group II)
          1. D07AB01 clobetasone
Marketing authorisation PL 00289/2324 (first authorised 18 January 2013)
Marketing authorisation holder Teva UK Limited
Codes BNF 13040000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.